Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis

Authors :: Justine Clarenne
Coralie Boulanger
Laetitia Visseaux
Antonin Maréchal
Florian Slimano
Source :: Journal of Oncology Pharmacy Practice. 26:1216-1219
Publication Year :: 2020
Publisher :: SAGE Publications, 2020.

Subjects :: Oncology
medicine.medical_specialty
biology
Healthcare financing
business.industry
Melanoma
MEDLINE
Pembrolizumab
Budget impact
medicine.disease
Internal medicine
Programmed cell death 1
medicine
biology.protein
Pharmacology (medical)
Nivolumab
business
Advanced melanoma

Full Text Access

Tools